United Therapeutics Ratios (2009-2026) | UTHR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	91.67%	93.77%	91.67%	94.39%	93.64%	92.79%	88.04%	89.68%	89.25%	88.50%	88.45%	89.24%	89.12%	88.90%	89.69%	88.36%	89.03%	87.38%	86.91%	82.93%
EBT Margin (Quarter)	48.49%	45.96%	33.84%	66.83%	32.26%	60.56%	36.38%	57.59%	56.19%	57.73%	48.06%	58.82%	49.70%	51.89%	53.88%	53.31%	51.14%	54.78%	56.19%	40.73%
EBIT Margin (Quarter)	49.76%	51.43%	40.90%	62.35%	43.22%	60.91%	35.73%	56.11%	52.54%	53.66%	42.31%	52.57%	44.75%	45.81%	48.61%	48.19%	45.64%	48.59%	45.14%	41.69%
EBITDA Margin (Quarter)	49.76%	51.43%	40.90%	62.35%	43.22%	60.91%	35.73%	56.11%	52.54%	53.66%	42.31%	52.57%	44.75%	45.81%	48.61%	48.19%	45.64%	48.59%	45.14%	41.69%
Operating Margin (Quarter)	49.76%	51.43%	40.90%	62.35%	43.22%	60.91%	35.73%	56.11%	52.54%	53.66%	42.31%	52.57%	44.75%	45.81%	48.61%	48.19%	45.64%	48.59%	45.14%	41.69%
Net Margin (Quarter)	38.66%	36.59%	27.02%	51.94%	24.84%	46.38%	26.88%	47.52%	43.45%	43.91%	35.32%	45.24%	38.90%	41.27%	40.94%	40.56%	38.76%	42.36%	46.10%	35.18%
FCF Margin (Quarter)	33.59%	31.19%	25.05%	59.58%	23.56%	53.35%	25.94%	70.31%	6.49%	65.21%	27.18%	52.07%	24.13%	40.15%	34.58%	48.63%	25.09%	35.11%	73.08%	46.54%
Efficiency
Inventory Average (Quarter)	91.05M	93.30M	95.25M	91.00M	89.05M	90.45M	96.50M	102.25M	102.90M	103.80M	108.05M	116.00M	128.35M	141.60M	152.30M	161.65M	167.30M	172.85M	179.80M	180.70M
Assets Average (Quarter)	4,742.95M	4,946.90M	5,109.00M	5,264.45M	5,451.55M	5,662.45M	5,913.05M	6,195.25M	6,513.65M	6,852.45M	7,095.30M	6,831.10M	6,609.20M	3,362.90M	3,683.30M	7,553.95M	7,825.95M	7,629.55M	7,615.55M	7,297.10M
Invested Capital (Quarter)										300.00M	400.00M	400.00M	400.00M	400.00M	300.00M	200.00M
Asset Utilization Ratio (Quarter)	0.34	0.33	0.33	0.34	0.33	0.33	0.33	0.32	0.32	0.32	0.33	0.37	0.40	0.82	0.78	0.40	0.39	0.41	0.42	0.43
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.56	0.53	36.13	0.75	0.26	0.54	14.28	0.49	0.59	0.58	17.23	0.65	0.31	0.28	68.79	0.44	0.50	0.28	115.06	0.18
Debt Ratio (Quarter)	0.17	0.16	0.15	0.15	0.14	0.14	0.13	0.13	0.12	0.11	0.10	0.09	0.07	153.85	0.04	0.03
Times Interest Earned (Quarter)	0.56	0.53	36.13	0.75	0.26	0.54	14.28	0.49	0.59	0.58	17.23	0.65	0.31	0.28	68.79	0.44	0.50	0.28	115.06	0.18
Valuation
Enterprise Value (Quarter)	-1967.50M	-2000.40M	-1930.70M	-2267.70M	-2255.20M	-2615.60M	-2838.70M	-2863.40M	-2679.00M	-2875.50M	-2994.10M	-2707.80M	-2971.50M	-3326.50M	-3267.00M	-3321.30M	-3048.70M	-2767.60M	-2920.30M	-2153.70M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	10.01%	9.76%	11.57%	18.28%	17.35%	18.22%	17.59%	16.63%	17.71%	18.01%	18.84%	21.05%	21.87%	51.39%	46.75%	20.54%	19.84%	21.08%	21.16%	21.43%
Return on Invested Capital (Quarter)											0.02%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%	0.03%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

United Therapeutics Ratios (2009-2026) | UTHR

Research Tools

Developers

United Therapeutics Ratios (2009-2026) | UTHR

Create an account

Sign In

Reset Password